Tumor markers in colorectal cancer, gastric cancer and gastrointestinal stromal cancers: European group on tumor markers 2014 guidelines update
出版年份 2013 全文链接
标题
Tumor markers in colorectal cancer, gastric cancer and gastrointestinal stromal cancers: European group on tumor markers 2014 guidelines update
作者
关键词
-
出版物
INTERNATIONAL JOURNAL OF CANCER
Volume 134, Issue 11, Pages 2513-2522
出版商
Wiley
发表日期
2013-07-14
DOI
10.1002/ijc.28384
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Systematic Review: Anti–Epidermal Growth Factor Receptor Treatment Effect Modification byKRASMutations in Advanced Colorectal Cancer
- (2013) Issa J. Dahabreh et al. ANNALS OF INTERNAL MEDICINE
- Strategies to Identify the Lynch Syndrome Among Patients With Colorectal Cancer
- (2013) Uri Ladabaum et al. ANNALS OF INTERNAL MEDICINE
- Phase II Study of Everolimus in Patients with Metastatic Colorectal Adenocarcinoma Previously Treated with Bevacizumab-, Fluoropyrimidine-, Oxaliplatin-, and Irinotecan-Based Regimens
- (2013) K. Ng et al. CLINICAL CANCER RESEARCH
- Rational Combination of a MEK Inhibitor, Selumetinib, and the Wnt/Calcium Pathway Modulator, Cyclosporin A, in Preclinical Models of Colorectal Cancer
- (2013) A. Spreafico et al. CLINICAL CANCER RESEARCH
- Antitumor activity of pimasertib, a selective MEK 1/2 inhibitor, in combination with PI3K/mTOR inhibitors or with multi-targeted kinase inhibitors in pimasertib-resistant human lung and colorectal cancer cells
- (2013) Erika Martinelli et al. INTERNATIONAL JOURNAL OF CANCER
- Risks of Colorectal and Other Cancers After Endometrial Cancer for Women With Lynch Syndrome
- (2013) Aung Ko Win et al. JNCI-Journal of the National Cancer Institute
- Adjuvant therapy in primary GIST: state-of-the-art
- (2012) P. Reichardt et al. ANNALS OF ONCOLOGY
- Her2/neu testing in gastric cancer: evaluating the risk of sampling errors
- (2012) V. S. Warneke et al. ANNALS OF ONCOLOGY
- Treatment with bevacizumab and FOLFOXIRI in patients with advanced colorectal cancer: presentation of two novel trials (CHARTA and PERIMAX) and review of the literature
- (2012) Alexander Stein et al. BMC CANCER
- A preclinical and clinical review of aflibercept for the management of cancer
- (2012) Andrew Gaya et al. CANCER TREATMENT REVIEWS
- Lynch syndrome diagnostics: decision-making process for germ-line testing
- (2012) Enrique Lastra et al. Clinical & Translational Oncology
- Molecular Tests for Colorectal Cancer Screening
- (2012) Linda J.W. Bosch et al. Clinical Colorectal Cancer
- Patient-Tailored Treatments with Anti-EGFR Monoclonal Antibodies in Advanced Colorectal Cancer: KRAS and Beyond
- (2012) A. Ballestrero et al. CURRENT CANCER DRUG TARGETS
- Targeted Therapy for Gastric Cancer
- (2012) Elizabeth C. Smyth et al. CURRENT TREATMENT OPTIONS IN ONCOLOGY
- Addition of cetuximab to chemotherapy as first-line treatment for KRAS wild-type metastatic colorectal cancer: Pooled analysis of the CRYSTAL and OPUS randomised clinical trials
- (2012) Carsten Bokemeyer et al. EUROPEAN JOURNAL OF CANCER
- Bevacizumab in colorectal cancer: current and future directions
- (2012) Yvonne Yeung et al. Expert Review of Anticancer Therapy
- Comparing Fecal Immunochemical Tests: Improved Standardization Is Needed
- (2012) James E. Allison et al. GASTROENTEROLOGY
- Identification of Lynch Syndrome Among Patients With Colorectal Cancer
- (2012) Leticia Moreira et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Cediranib With mFOLFOX6 Versus Bevacizumab With mFOLFOX6 As First-Line Treatment for Patients With Advanced Colorectal Cancer: A Double-Blind, Randomized Phase III Study (HORIZON III)
- (2012) Hans-Joachim Schmoll et al. JOURNAL OF CLINICAL ONCOLOGY
- Association ofKRASG13D Tumor Mutations With Outcome in Patients With Metastatic Colorectal Cancer Treated With First-Line Chemotherapy With or Without Cetuximab
- (2012) Sabine Tejpar et al. JOURNAL OF CLINICAL ONCOLOGY
- Integrated Analysis of Molecular and Clinical Prognostic Factors in Stage II/III Colon Cancer
- (2012) A. D. Roth et al. JNCI-Journal of the National Cancer Institute
- A Proposal to Standardize Reporting Units for Fecal Immunochemical Tests for Hemoglobin
- (2012) C. G. Fraser et al. JNCI-Journal of the National Cancer Institute
- Regorafenib monotherapy for previously treated metastatic colorectal cancer (CORRECT): an international, multicentre, randomised, placebo-controlled, phase 3 trial
- (2012) Axel Grothey et al. LANCET
- TFAP2E–DKK4and Chemoresistance in Colorectal Cancer
- (2012) Matthias P.A. Ebert et al. NEW ENGLAND JOURNAL OF MEDICINE
- Elevated Preoperative Carcinoembryonic Antigen (CEA) and Ki67 Is Predictor of Decreased Survival in IIA Stage Colon Cancer
- (2012) Yifan Peng et al. WORLD JOURNAL OF SURGERY
- A future for faecal haemoglobin measurements in the medical laboratory
- (2012) C. G. Fraser ANNALS OF CLINICAL BIOCHEMISTRY
- PIK3CA exon 20 mutations as a potential biomarker for resistance to anti-EGFR monoclonal antibodies in KRAS wild-type metastatic colorectal cancer: a systematic review and meta-analysis
- (2011) C. Mao et al. ANNALS OF ONCOLOGY
- Septin 9 methylated DNA is a sensitive and specific blood test for colorectal cancer
- (2011) Jorja D Warren et al. BMC Medicine
- Clinical impact of anti-epidermal growth factor receptor monoclonal antibodies in first-line treatment of metastatic colorectal cancer
- (2011) Fotios Loupakis et al. CANCER
- Molecular mechanisms of resistance to the EGFR monoclonal antibody cetuximab
- (2011) Toni M. Brand et al. CANCER BIOLOGY & THERAPY
- Colon Cancer Screening: Which Non-Invasive Filter Tests?
- (2011) Christian Pox DIGESTIVE DISEASES
- Comparison between universal molecular screening for Lynch syndrome and revised Bethesda guidelines in a large population-based cohort of patients with colorectal cancer
- (2011) Lucía Pérez-Carbonell et al. GUT
- Cost-effectiveness of KRAS testing in metastatic colorectal cancer patients in the United States and Germany
- (2011) Arthi Vijayaraghavan et al. INTERNATIONAL JOURNAL OF CANCER
- Development and Independent Validation of a Prognostic Assay for Stage II Colon Cancer Using Formalin-Fixed Paraffin-Embedded Tissue
- (2011) Richard D. Kennedy et al. JOURNAL OF CLINICAL ONCOLOGY
- Validation Study of a Quantitative Multigene Reverse Transcriptase–Polymerase Chain Reaction Assay for Assessment of Recurrence Risk in Patients With Stage II Colon Cancer
- (2011) Richard G. Gray et al. JOURNAL OF CLINICAL ONCOLOGY
- Value of Mismatch Repair, KRAS, and BRAF Mutations in Predicting Recurrence and Benefits From Chemotherapy in Colorectal Cancer
- (2011) Gordon Hutchins et al. JOURNAL OF CLINICAL ONCOLOGY
- Microsatellite Instability and Loss of Heterozygosity at Chromosomal Location 18q: Prospective Evaluation of Biomarkers for Stages II and III Colon Cancer—A Study of CALGB 9581 and 89803
- (2011) Monica M. Bertagnolli et al. JOURNAL OF CLINICAL ONCOLOGY
- Identification of Individuals at Risk for Lynch Syndrome Using Targeted Evaluations and Genetic Testing: National Society of Genetic Counselors and the Collaborative Group of the Americas on Inherited Colorectal Cancer Joint Practice Guideline
- (2011) Scott M. Weissman et al. Journal of Genetic Counseling
- Fecal Occult Blood Testing When Colonoscopy Capacity is Limited
- (2011) Janneke A. Wilschut et al. JNCI-Journal of the National Cancer Institute
- C-stage in Colon Cancer: Implications of Carcinoembryonic Antigen Biomarker in Staging, Prognosis, and Management
- (2011) Pragatheeshwar Thirunavukarasu et al. JNCI-Journal of the National Cancer Institute
- Stool DNA screening for colorectal neoplasia: biological and technical basis for high detection rates
- (2011) Barry M. Berger et al. PATHOLOGY
- Primary colon cancer: ESMO Clinical Practice Guidelines for diagnosis, adjuvant treatment and follow-up
- (2010) R. Labianca et al. ANNALS OF ONCOLOGY
- Clinical Significance of CEA and CA19-9 in Postoperative Follow-up of Colorectal Cancer
- (2010) Tomomi Yakabe et al. ANNALS OF SURGICAL ONCOLOGY
- Tumor Marker Evolution: Comparison with Imaging for Assessment of Response to Chemotherapy in Patients with Colorectal Liver Metastases
- (2010) Robbert J. de Haas et al. ANNALS OF SURGICAL ONCOLOGY
- Intensive Risk-Adjusted Follow-up With the CEA, TPA, CA19.9, and CA72.4 Tumor Marker Panel and Abdominal Ultrasonography to Diagnose Operable Colorectal Cancer Recurrences
- (2010) Andrea Nicolini ARCHIVES OF SURGERY
- Cost-effectiveness of colorectal cancer screening – An overview
- (2010) Iris Lansdorp-Vogelaar et al. BEST PRACTICE & RESEARCH IN CLINICAL GASTROENTEROLOGY
- Perspective on updated treatment guidelines for patients with gastrointestinal stromal tumors
- (2010) Jean-Yves Blay et al. CANCER
- All about KRAS for clinical oncology practice: Gene profile, clinical implications and laboratory recommendations for somatic mutational testing in colorectal cancer
- (2010) Helena Linardou et al. CANCER TREATMENT REVIEWS
- Preoperative plasma TIMP-1 is an independent prognostic indicator in patients with primary colorectal cancer: A prospective validation study
- (2010) Helgi Birgisson et al. EUROPEAN JOURNAL OF CANCER
- Microsatellite instability as a marker of prognosis and response to therapy: A meta-analysis of colorectal cancer survival data
- (2010) Cecilia Guastadisegni et al. EUROPEAN JOURNAL OF CANCER
- Towards global consensus in the treatment of gastrointestinal stromal tumor
- (2010) Peter Reichardt et al. Expert Review of Anticancer Therapy
- One to 2-Year Surveillance Intervals Reduce Risk of Colorectal Cancer in Families With Lynch Syndrome
- (2010) Hans F.A. Vasen et al. GASTROENTEROLOGY
- Microsatellite Instability in Colorectal Cancer
- (2010) C. Richard Boland et al. GASTROENTEROLOGY
- DOG1 and CD117 are the antibodies of choice in the diagnosis of gastrointestinal stromal tumours
- (2010) Marco Novelli et al. HISTOPATHOLOGY
- Use of faecal markers in screening for colorectal neoplasia: a European group on tumor markers position paper
- (2010) Michael J. Duffy et al. INTERNATIONAL JOURNAL OF CANCER
- Colorectal cancer screening comparing no screening, immunochemical and guaiac fecal occult blood tests: A cost-effectiveness analysis
- (2010) Leo G.M. van Rossum et al. INTERNATIONAL JOURNAL OF CANCER
- Cost-effectiveness analysis of the optimal threshold of an automated immunochemical test for colorectal cancer screening: Performances of immunochemical colorectal cancer screening
- (2010) Célia Berchi et al. INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE
- Association of KRAS p.G13D Mutation With Outcome in Patients With Chemotherapy-Refractory Metastatic Colorectal Cancer Treated With Cetuximab
- (2010) Wendy De Roock et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- EGFR Antibodies in Colorectal Cancer: Where Do They Belong?
- (2010) Axel Grothey JOURNAL OF CLINICAL ONCOLOGY
- Defective Mismatch Repair As a Predictive Marker for Lack of Efficacy of Fluorouracil-Based Adjuvant Therapy in Colon Cancer
- (2010) Daniel J. Sargent et al. JOURNAL OF CLINICAL ONCOLOGY
- Molecular Mechanisms of Resistance to Cetuximab and Panitumumab in Colorectal Cancer
- (2010) Alberto Bardelli et al. JOURNAL OF CLINICAL ONCOLOGY
- Clinical Relevance of Microsatellite Instability in Colorectal Cancer
- (2010) Albert de la Chapelle et al. JOURNAL OF CLINICAL ONCOLOGY
- Gene Expression Signature to Improve Prognosis Prediction of Stage II and III Colorectal Cancer
- (2010) Ramon Salazar et al. JOURNAL OF CLINICAL ONCOLOGY
- Comparison of immunochemical and guaiac-based fecal occult blood test in screening and surveillance for advanced colorectal neoplasms: A meta-analysis
- (2010) Ming Ming ZHU et al. Journal of Digestive Diseases
- The GIST paradigm: lessons for other kinase-driven cancers
- (2010) Cristina R Antonescu JOURNAL OF PATHOLOGY
- Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial
- (2010) Yung-Jue Bang et al. LANCET
- Effects of KRAS, BRAF, NRAS, and PIK3CA mutations on the efficacy of cetuximab plus chemotherapy in chemotherapy-refractory metastatic colorectal cancer: a retrospective consortium analysis
- (2010) Wendy De Roock et al. LANCET ONCOLOGY
- Mismatch repair deficient colorectal cancer in the era of personalized treatment
- (2010) Madeleine Hewish et al. Nature Reviews Clinical Oncology
- Understanding resistance to EGFR inhibitors—impact on future treatment strategies
- (2010) Deric L. Wheeler et al. Nature Reviews Clinical Oncology
- HER2 diagnostics in gastric cancer—guideline validation and development of standardized immunohistochemical testing
- (2010) Josef Rüschoff et al. VIRCHOWS ARCHIV
- The impact of carcinoembryonic antigen flare in patients with advanced colorectal cancer receiving first-line chemotherapy
- (2009) A. S. Strimpakos et al. ANNALS OF ONCOLOGY
- Serum Carcinoembryonic Antigen Monitoring After Curative Resection for Colorectal Cancer: Clinical Significance of the Preoperative Level
- (2009) In Ja Park et al. ANNALS OF SURGICAL ONCOLOGY
- Preoperative serum carcinoembryonic antigen, albumin and age are supplementary to UICC staging systems in predicting survival for colorectal cancer patients undergoing surgical treatment
- (2009) Li-Chu Sun et al. BMC CANCER
- Does microsatellite instability predict the efficacy of adjuvant chemotherapy in colorectal cancer? A systematic review with meta-analysis
- (2009) Gaëtan Des Guetz et al. EUROPEAN JOURNAL OF CANCER
- EGAPP supplementary evidence review: DNA testing strategies aimed at reducing morbidity and mortality from Lynch syndrome
- (2009) Glenn E Palomaki et al. GENETICS IN MEDICINE
- Caution Is Required Before Recommending Routine Carcinoembryonic Antigen and Imaging Follow-Up for Patients With Early-Stage Colon Cancer
- (2009) Michael Chao et al. JOURNAL OF CLINICAL ONCOLOGY
- Postoperative Surveillance Recommendations for Early Stage Colon Cancer Based on Results From the Clinical Outcomes of Surgical Therapy Trial
- (2009) Vassiliki L. Tsikitis et al. JOURNAL OF CLINICAL ONCOLOGY
- Effect of Rising Chemotherapy Costs on the Cost Savings of Colorectal Cancer Screening
- (2009) Iris Lansdorp-Vogelaar et al. JNCI-Journal of the National Cancer Institute
- Use of Archived Specimens in Evaluation of Prognostic and Predictive Biomarkers
- (2009) R. M. Simon et al. JNCI-Journal of the National Cancer Institute
- Serum tumour markers: how to order and interpret them
- (2009) C M Sturgeon et al. BMJ-British Medical Journal
- Surveillance after Curative Resection of Colorectal Cancer
- (2009) Adena Scheer et al. Clinics in Colon and Rectal Surgery
- Cochrane Systematic Review of Colorectal Cancer Screening Using the Fecal Occult Blood Test (Hemoccult): An Update
- (2008) Paul Hewitson et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines for Use of Tumor Markers in Testicular, Prostate, Colorectal, Breast, and Ovarian Cancers
- (2008) C. M. Sturgeon et al. CLINICAL CHEMISTRY
- The efficacy of adjuvant chemotherapy with 5-fluorouracil in colorectal cancer depends on the mismatch repair status
- (2008) Rodrigo Jover et al. EUROPEAN JOURNAL OF CANCER
- Clinical practice guidelines for gastrointestinal stromal tumor (GIST) in Japan: English version
- (2008) Toshirou Nishida et al. International Journal of Clinical Oncology
- Usefulness of the Serum Carcinoembryonic Antigen Kinetic for Chemotherapy Monitoring in Patients With Unresectable Metastasis of Colorectal Cancer
- (2008) Isabelle Iwanicki-Caron et al. JOURNAL OF CLINICAL ONCOLOGY
- Correlation of Kinase Genotype and Clinical Outcome in the North American Intergroup Phase III Trial of Imatinib Mesylate for Treatment of Advanced Gastrointestinal Stromal Tumor: CALGB 150105 Study by Cancer and Leukemia Group B and Southwest Oncology Group
- (2008) Michael C. Heinrich et al. JOURNAL OF CLINICAL ONCOLOGY
- Phase III Randomized, Intergroup Trial Assessing Imatinib Mesylate At Two Dose Levels in Patients With Unresectable or Metastatic Gastrointestinal Stromal Tumors Expressing the Kit Receptor Tyrosine Kinase: S0033
- (2008) Charles D. Blanke et al. JOURNAL OF CLINICAL ONCOLOGY
- Cost evaluation in a colorectal cancer screening programme by faecal occult blood test in the District of Florence
- (2008) Grazia Grazzini et al. JOURNAL OF MEDICAL SCREENING
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation